Evotec SE (NASDAQ:EVO) Q3 2023 Earnings Call Transcript

Werner Lanthaler: Welcome to our -- good morning. Good afternoon. Welcome to our Q3 Call. Resilient into the Future of Biopharma R&D.

Keep Reading →